Firms To Watch: Industry focus: Healthcare and life sciences

EY TAX & LAW ITALY, led by Aldo Brielli, assists clients on regulatory, administrative, liability, commercial and IP matters for clients in the healthcare and life sciences sector.

Industry focus: Healthcare and life sciences in Italy

Bird & Bird

Bird & Bird provide a complete service to its clients in the healthcare and life sciences sectors. It advises on IP, regulatory, transactional corporate, EU and competition, data protection and dispute resolution matters. Massimiliano Mostardini and Giovanni Galimberti head the practice, both focusing on IP matters affecting the sector including trademarks, copyright and unfair competition. Within the practice, Antonella De Gregori utilises her specialist knowledge in the pharmaceutical sector, and Claudia Ricciardi drafts and negotiates patent/know how licences and assignment agreements. Evelina Marchesoni and Mauro Turrini are also of note. In May 2023, Elisabetta Bandera and Rita Tardiolo were made partners.

Practice head(s):

Giovanni Galimberti; Massimiliano Mostardini

Other key lawyers:

Antonella De Gregori; Claudia Ricciardi; Evelina Marchesoni; Mauro Turrini; Elisabetta Bandera; Rita Tardiolo


‘They provide innovative ideas/solutions to complex issues. Teams properly formed with lawyers and patent attorneys. Good communication skills. Good timing in work delivery.’

‘Good knowledgeable team with sensible commercial advice.’

‘Giovanni Galimberti is very easy to work with and gives excellent commercial advice.’

Key clients

Alcon Italia

Astellas Pharma



Fisher & Paykel

Gruppo San Donato

Heska Corporation


Istituto Europeo di Oncologia

ISchema View

Kyowa Kirin Italia

Multimedica Clinical & Research Campus


Polpharma group

San Donato Group

San Raffaele Hospital

Swiss Pharma International

Telethon Foundation

Work highlights

  • Assisted Instituto Nazionale Genetica Molecolare in connection with the conferment of a patent in T-One Therapeutics, a newly established company in which the Utopia Fund invested.
  • Assisting Swiss Pharma International in invalidity proceedings before the Court of Rome, related to a patent claiming a dosage regimen of the active ingredient natalizumab for the treatment of multiple sclerosis owned by Biogen.
  • Assisted Gruppo San Donato in the creation of a contractual joint venture with Microsoft for the creation of an AI Center of Excellence for the development of artificial intelligence systems to treat certain type of cancers and other clinical projects.


The multidisciplinary practice at BonelliErede assists its clients in the healthcare and life sciences sectors in all manner of matters. The firm has deep knowledge of the pharmaceutical and biomedical markets, advising on matters involving EU and competition law, litigation, administrative issues, M&A, IP and tax. Other notable members within the practice include managing partner Andrea Carta Mantiglia, who specialises in M&A, litigation and international arbitration within the sector, and IP specialist Giovanni Guglielmetti. Sarah Lembo‘s broad expertise includes a focus on EU and anti-trust law. Vincenzo Salvatore left the practice in March 2024.

Other key lawyers:

Sarah Lembo; Andrea Carta Mantiglia; Giovanni Guglielmetti


High experience, broad capabilities and different expertises inside the BE team that can support in complex projects/discussions. Flexible and smart in finding the right solution for the customer (adapting to customer needs). Reactive and fast when there is urgency.’

Key clients

Amylyx Pharmaceuticals

Bausch & Lomb


Bracco Imaging

Chiesi Farmaceutici

CSL Behring









Pharming Group




Work highlights

  • Assisting Biogen in challenging the approval of a generic medicine, the sale of which could constitute an anti-competitive measure for Biogen.
  • Assisted Amylyx Pharmaceuticals during the assessment procedure before the EMEA CHMP for the launch of an innovative drug for AML.
  • Providing Pharming Group with ongoing legal support on regulatory aspects and the drafting of commercial contracts (e.g. sponsorship agreements).

DLA Piper

DLA Piper’s healthcare and life sciences practice spans the sector, with experience in corporate, regulatory, public procurement, privacy, IP, competition and litigation. The firm advises major players in the industry, including national and multinational pharmaceutical corporations, on domestic and cross-border matters. Roberto Valenti is the head of the department at the firm; he advises on IP litigation and commercial matters in the life science sectors, with particular expertise on matters involving medical devices. Marco de Morpurgo focuses on the EU and national regulation of pharmaceuticals, biotech and medical devices. Raffaella Quintana (compliance and criminal law) and Gualtiero Dragotti (IP) can bring their considerable talents to this sector.

Practice head(s):

Roberto Valenti

Other key lawyers:

Marco de Morpurgo; Raffaella Quintana; Gualtiero Dragotti


‘The team is well prepared, open and available to specific requests. They are also skilled at managing discussions and talented. ’

‘Empathetic and personalized customer management.’

‘Acumen, sophistication, and the ability to interpret not only the laws but also environmental situations.’

‘Roberto Valenti is a very open leader, capable of managing discussions and finding the right compromise on discussed issues.’

‘Strong work ethic. Adaptable. Problem solving and analytical thinking.’

‘Marco de Morpurgo is a go-to at DLA. He is an extremely reliable partner. He ensures the right lawyers in DLA’s broad network.’

‘The team is very competent and has a great deal of experience in the matter that interests my company.’

Key clients

Pfizer Inc.


Iovance Biotherapeutics

Vertex Pharmaceuticals



Menarini Group


Reckitt Benkiser

GE Healthcare

Work highlights

  • Advised Pfizer Inc. with regard to the agreement for the supply of their Covid-19 Vaccine across Europe.
  • Assisting Medtronic Inc. in a patent dispute among European leading manufacturers and suppliers of a range of medical devices for respiratory support, in connection with the alleged infringement of two European patents referred to devices for oxygen administration in the intensive therapy.
  • Assisted Sifi S.p.A. in the implementation of the license agreement regarding SIFI IP (including a patent which is crucial for the manufacture of the product) for the manufacturing and marketing of intra-ocular lenses and other surgical devices for the treatment of eye diseases in Greater China.

Herbert Smith Freehills

Herbert Smith Freehills assists clients on matters across the healthcare and life sciences spectrum, such as IP disputes, regulation and compliance issues, white-collar crime investigations, clinical trials, privacy issues and financings. Managing partner Laura Orlando leads the practice alongside assisting clients in IP-related healthcare and life sciences matters, with a particular focus on patent litigation in the pharmaceutical, biotech and chemical sectors. Within the team, Sara Balice assists clients in matters concerning patents, trademarks, copyright, design, unfair competition and trade secrets. In February 2023, Augusto Santoro joined the firm from Simmons & Simmons.

Practice head(s):

Laura Orlando

Other key lawyers:

Sara Balice


‘Really business oriented and proactive.’

‘This is a firm that really does have outstanding commercial knowledge of the industry.’

‘They are genuine business partners with a very innovative approach to advising clients.’

Key clients



Achilles Vaccines


Eli Lilly


Lionhealth Srl


Millennium Pharmaceuticals (Takeda)


Pharma Prime

Philips S.p.A.



The US Government



Work highlights

Hogan Lovells International LLP

Hogan Lovells International LLP combines practices to ensure all matters arising in the healthcare and life sciences industries can be dealt with, including M&A, commercial, regulatory, product liability, IP, compliance and litigation. The firm also maintains a good relationship with the Italian health authorities. The practice is led by Christian Di Mauro, who has a focus on product liability, safety, compliance and regulation. Within the healthcare and life sciences department, Giuseppe Aminzade is highly knowledgeable in pharmaceutical law, medical liability and administrative law affecting the industry. Chiara Perolari is also noted for her assistance in regulatory matters and clinical trial support.

Practice head(s):

Christian Di Mauro

Other key lawyers:

Giuseppe Aminzade; Chiara Perolari


‘Giuseppe Aminzade is a strategically thinking attorney who always sees the full picture.’

‘Good knowledge about medical devices and its business practices.’

‘Christian di Mauro is an excellent lawyer. His whole team is provides excellent support.’

Key clients

Angelini Holding

Baxter AG, Baxter S.p.A

CHR Hansen Italia

Eli Lilly

Fidia Farmaceutici S.p.A.

Formula Pharmaceuticals Inc.

GE Healthcare


Livanova PLC


Qiagen Marseille

Recordati S.p.A.

Sorin Group

Takeda Shire

Work highlights

Portolano Cavallo

Portolano Cavallo advises major healthcare and life sciences clients on transactional/contractual, IP, compliance and regulatory, product liability and litigation matters. Luca Gambini and Elisa Stefanini lead the practice group. Gambini has a particular strength in M&A transactions relating to the life sciences sector, whilst Stefanini focuses on regulatory and compliance matters for pharma, biotech and med-tech clients. Andrea Gritti joined the firm from Gianni & Origoni in March 2023, with Gianpaolo Scandone following from Gatti Pavesi Bianchi Ludovici in June 2023. In July 2023, Enzo Marasà was promoted to partner.

Practice head(s):

Elisa Stefanini; Luca Gambini

Other key lawyers:

Andrea Gritti; Gianpaolo Scandone; Enzo Marasà


‘Fully reliable team; technically expert; innovative entrepreneurial approach.’

‘Independent firm able to mobilize resources while innovating in its services.’

Fully reliable team with a cost effective approach, technically expert, innovative Entrepreneurial approach Independant firm able to mobilize resources while innovating in its services.’

The team led by Elisa Stefanini is capable of providing extremely accurate legal opinions with a practical and concrete approach, taking into account the peculiarity of each case. There is always extreme clarity in communications and great attention to timing. I really appreciate the focus on industry standards and developments.’

Work highlights



ADVANT Nctm assists the full range of actors in the healthcare and life sciences sector, from manufacturers and pharmaceutical companies to regulators, investors and public-private partnerships. The firm draws talent from across departments to cater to each matter, be it IP, anti-trust or administrative. The two heads of the healthcare and life sciences practice are Lorena Possagno, who focuses on corporate and commercial assistance, and Paolo Gallarati, who specialises in international transactions and compliance in life sciences. In 2023, both Jacopo Arnaboldi and Giulio Uras were promoted to partner.

Practice head(s):

Lorena Possagno; Paolo Gallarati

Other key lawyers:

Jacopo Arnaboldi; Giulio Uras


‘The team is professional and responsive. They put client’s interest as top priority in negotiations.’

‘The partner Lorena Possagno plays a critical role in projects and helps non-EU client understand EU listing regulations.’

‘Extremely supportive, professional, dynamic and decisive team.’

‘A really professional team. No matter what problem you have, there is always the right lawyer to talk to and drill into issues to get solutions.’

‘Lorena Possagno is very professional and with the first target to not have a dispute but to reach a compromise.’

‘Committed to clients success.’

‘Advant Nctm team is pragmatic, efficient and really problem solving oriented. The team is also very proactive and knows very well the the different industries/sectors.’

‘Lorena Possagno is an exceptional negotiator and communicator.’

Key clients

Astrazeneca S.p.A.

Fresenius Group

Gilead Sciences S.r.l.

Doc Generici S.r.l.

Genetic S.p.A.


Allovir Inc.

Circassia Pharmaceuticals Ltd

Uriach Italy

Opocrin S.p.A.

Astrazeneca S.p.A.

Ream SGR S.p.A.

Gilead Sciences S.r.l.

Doc Generici S.r.l.

Genetic S.p.A.

Advanced Medtech

Work highlights

  • Assisting Fresenius Group in relation to a wide array of legal services, such as a) dealing with AIFA and Public Administration; b) IP issues/intellectual property protection; c) legal issues related to compliance topics; d) legal issues related to employment agreements and labour topics; and e) corporate governance.
  • Assisted Mediolanum Farmaceutici in relation to the sale of an undisclosed percetange of Neopharmed Gentili, another Italian pharmaceutical company owned also by French Private Equity fund Ardiani and by Del Bono family to the Luxembourg Private Equity fund NB Renaissance. Value: EUR 1,5 billion.
  • Assisting AstraZeneca S.p.A. in relation to data protection matters.

Studio Professionale Associato a Baker & McKenzie

Studio Professionale Associato a Baker & McKenzie’s expertise stretches across the healthcare and life sciences sector with the ability to advise on regulatory, compliance, IP, clinical trials, disputes and administrative issues. The firm is experienced with the plethora of contentious issues that may affect its clients. Roberto Cursano leads the firm’s healthcare and life sciences practice. He frequently assists clients with regulations, contract law, pricing, clinical trial, public procurement and anti-bribery matters. Within the practice, Mario Cigno is noted for advising clients on regulatory matters, including public tender, clinical investigations and recalls.

Practice head(s):

Roberto Cursano

Other key lawyers:

Mario Cigno


‘They are all really top quality.’

‘The individuals are excellent.’

‘Baker’s team is remarkable insofar that they are always available, pleasant to work with and multi-facetted. On top, while providing sound legal advise and risk assessment, they remain pragmatic and solution oriented.’

Key clients

Regeneron Pharmaceuticals

ICU Medical Group


Abbott S.r.l.

Hartmann Group



Integra Lifesciences



Wolters Kluwer Health Inc.


Meridian Bioscience


Bio-Rad Laboratories


Applied Medical


Work highlights

  • Assisting several med-tech companies, amongst which, ICU Medical Group, Hartmann Group, Crossmed S.p.A., Integra Lifesciences, Vyaire, Meridian Bioscience, Bio-rad Laboratories, Illumina and Applied Medical in the context of legal proceedings, for an overall value of millions of Euro, to challenge payment orders issued by Italian authorities pursuant to the Italian legislation on the payback for medical devices.
  • Assisting Regeneron on a wide range of regulatory, corporate and commercial matters related to the incorporation of a new legal entity in Italy in connection with a global expansion project.
  • Assisting Intervet, a company of Merck group, in connection with the acquisition of several plots of lands in the area of Aprilia (Rome), to be used as an industrial site by the company.


Chiomenti maintains a dedicated multidisciplinary team for the healthcare and life sciences industry. It regularly advises on acquisitions and broader corporate matters in addition to areas such as tax planning, compliance and anti-trust. Its clients range from pharma manufacturers, research companies and producers of medical devices to companies that offer healthcare and hospital services. Luca Liistro leads the practice group whilst assisting clients on corporate and commercial matters. Filippo Brunetti advises on a range of corporate matters, pricing and market access together with compliance issues (he liaises with various authorities such as the Italian Pharmaceutical Agency. Corporate/M&A specialist Francesca Villa includes a number of pharma and medtech companies among her clients.

Practice head(s):

Luca Liistro

Other key lawyers:

Filippo Brunetti; Francesca Villa


‘Very sound knowledge of the HC and life science sector. Pro-active approach. Very reliable. Super competent.’

‘Strong expertise in the health sector which is highly regulated; proactive approach anticipating potential issues/concerns.

‘Luca Liistro has a strong commitment and is business oriented.’

Key clients

Abbott S.p.A.

Air Liquide Sanità Service

Albis International






Carestream Dental Italy


Columbus Education Association

Fidia Farmaceutici S.p.A.

Forest Laboratories

Gilead Sciences

Groupe Simago SAS


Laboratoires Expanscience

Lifebrain Group

LifeNet Health

Menarini Group

Merck Sharp & Dohme (Italia)

M.I.T. Italia S.r.l.



Roche S.p.A.

SoBi Pharma

Sophia Genetics


Techwald Holding

Xvivo Perfusion

Zambon Group


Work highlights

  • Advising Alfasigma S.p.A. in relation to the acquisition of the entire corporate capital of Sofar S.p.A., an Italian pharmaceutical company active in the research, production and marketing of drugs, medical devices and dietary supplements and specialized in the gastrointestinal area.
  • Advising Groupe Simago SAS, a leader group in the imaging diagnostic in France, in its first investment in Italy through the acquisition of the entire corporate capital of Gemini2 S.r.l., a local Italian imaging diagnostic company.
  • Advising Fidia Farmaceutici S.p.A. in relation to the acquisition from Sanofi Aventis of pharmaceutical assets.


Dentons advises clients from all sides of the healthcare and life sciences sector, including public and private bodies. The firm leverages its multidisciplinary practice to draw the requisite expertise for each matter brought by a client, from corporate to administrative. The head of the practice is Luca Pocobelli, who is greatly experienced in assisting major domestic and international clients on corporate and M&A matters related to healthcare and life sciences. Within the practice, Ilaria Gobbato advises clients through public procurement procedures and project financing.

Practice head(s):

Luca Pocobelli

Other key lawyers:

Ilaria Gobbato


‘Real dealmakers, without exposing clients to hidden risks; full practice coverage; hands-on attitude; 100% committed to the client; excellent network in the life-science industry (Italy and abroad).’

They know very well the market and they can offer always a good balance between cost and result.’

‘The strengths are certainly the speed of responses and the possibility of having experienced professionals in different fields within the same firm.’

‘Luca Pocobelli, in addition to his undisputed skills, has the human relationship established that makes all the difference.’

‘In the firm there is fast, experienced partners in a wide variety of fields. This is essential for a company that needs support in different areas.’

Key clients

Johnson & Johnson

Fujifilm Italia

Cerba HealthCare

ArchiMed SAS

Alliance Medical

Quinta Capital SGR

Amdipharm (Advanz Pharma)

Newron Pharmaceuticals


Work highlights

  • Advising Cerba HealthCare, a leading group that invests in the laboratory diagnostics sector across Europe, on several acquisitions (more than 200 in 2014 – 2023 period), including the recent acquisition of Centro Diagnostico Gamma S.r.l., a laboratory group operating in Calabria.
  • Assisting ArchiMed, a French private equity fund focused on the healthcare industry, in connection with the sale of Micromed Holding SAS, a global provider of neurophysiology solutions, to Natus Medical Incorporated, a leading provider of medical device solutions focused on the screening, diagnosis and treatment of central nervous and sensory system disorders.
  • Assisting Alliance Medical, a European leading diagnostic imaging company, in relation to the acquisition of Luccioli, a company operating a major multi-specialty medical and diagnostic centre in Italy.

Gitti and Partners

Gitti and Partners centres IP and regulatory work within its healthcare and life sciences practices. In addition, the firm functions as a one-stop-shop for its clients, assisting with corporate and M&A, commercial, data protection, administrative, employment and litigation matters. Its clients include domestic and international corporations with interests inside Italy. Paola Sangiovanni is the lead for life sciences with a focus on commercial, corporate and regulatory matters, including acquisitions, licence agreements and the drafting and negotiation of contracts. Flavio Monfrini  is a key team member, advising life sciences and new technology clients on corporate and commercial law and regulatory issues.

Practice head(s):

Paola Sangiovanni

Other key lawyers:

Flavio Monfrini


‘Great professionalism, preparation in every legal area and professional conduct based on profound ethics and attention to customer needs.’

‘Paola Sangiovanni has great preparation and professionalism as well as a profound capacity for mediation and humanity.’

‘The team is always helpful and professional. You can count on many professionals who specialize in every subject of business.’

‘They are truly experts in the industry and their partnership style has made them indispensable.’

‘They are so far ahead of their competitors that we genuinely struggle to differentiate between the also-rans to decide who would be runner up.’

‘Very well integrated and complementary team.’

‘Highly dedicated, competent and capable to tailor a highly professional and personalized relationship with the client.’

‘Paola Sangiovanni has a remarkable breadth of expertise that she uses to respond quickly, practically, and precisely to all our inquiries.’

Key clients

Nihon Kohden

Albireo Pharma Inc.

Emergent Biosolutions Inc.

Huvant S.r.l.

Work highlights

  • Assisting Albireo Pharma and Emergent Biosolutions in the corporate transactions resulting in the sale of their business.
  • Litigating high profile cases against the Ministry of Health, Italian regions and the Italian Data Protection Authority on behalf of Artivion, Stago and Medtronic.
  • Assessing complex regulatory questions for Haemopharm Biofluids (Mozarc), Novartis, 3M Health Care, AirLiquide, Goodwin Procter, Shionogi and the fund Clessidra.

Orrick, Herrington & Sutcliffe

Orrick, Herrington & Sutcliffe provides a full coverage of the healthcare and life sciences sector, advising on competition, M&A, commercial agreements, regulatory, data protection, litigation and white-collar crime matters. The firm’s capabilities also include supporting domestic and international firms with cross-border matters. Jean-Paule Castagno is experienced in white-collar crime matters, including litigation and crisis management. Attilio Mazzilli assists clients through corporate and M&A - advising on major pharmaceutical transactions. Pietro Merlino left the practice for Legance - Avvocati Associati in November 2023.

Practice head(s):

Jean-Paule Castagno; Attilio Mazzilli


‘Very helpful and cooperative.’

‘Always attentive to the company’s best interests: Andrea Alfonso Stigliano, Livia Maria Pedroni, Attilio Mazzilli.’

Key clients

F. Hoffmann-La Roche SA

Kedrion – Sestant Internazionale

Healthware Group S.r.l.

Bianalisi S.p.A.

Cerba HC Italia S.r.l.

Allelica S.r.l.

Garofalo Health Care S.p.A.

Artsana Group


Work highlights

  • Assisted Kedrion and its parent company Sestant Internazionale on the global merger control aspects (except the US) of a complex transaction whereby PE fund Permira and Sestant acquire joint control over Kedrion – currently solely controlled by Sestant – and Bio Products Laboratory Limited.
  • Assisted Philogen S.p.A., an Italian-Swiss company active in the biotechnology sector, for all negotiation aspects – including the IP profiles – concerning the licensing agreement with Sun Pharmaceutical Industries Limited for commercializing Philogen’s specialty product, Nidlegy™ (Daromun) in the territories of Europe, Australia and New Zealand. Nidlegy™.
  • Advised 1000 Farmacie, an Italy based company that operates an online shopping platform intended to offer a wide range of pharmaceutical products, in its €15 million financing.

Osborne Clarke

Osborne Clarke assists clients from across the healthcare and life sciences sector on major and complex M&A deals as well as on competition law. The firm is also well-versed in supporting clients through IP, regulatory and compliance matters. Maria Grazia Medici is the head of the life sciences team at the firm and specialises in the regulation of pharmaceutical products, active substances and medical devices. Within the team, Giulia Verusio provides experience in corporate and commercial law as well as pharmaceutical litigation.

Practice head(s):

Maria Grazia Medici

Other key lawyers:

Giulia Verusio


‘Giulia Verusio is an outstanding and valuable business partner to our company. She has never failed to provide us with business minded and legally sound advice.’

‘It’s evident that their team is not just well-versed in legal matters but also possesses a profound knowledge of the science and technology that underpins the sector. This unique blend of legal expertise and scientific acumen is a game-changer for anyone operating in the life sciences field.’

‘Giulia Verusio demonstrates an excellent preparation and knowledge of the health/science sector and is superb in giving her advice and managing the whole case.’

‘Their multidisciplinary team is a treasure trove of talent.’

‘I felt like more than just a client; I felt like a partner. Their team genuinely cares about the outcomes they achieve for their clients, and it’s evident in the personal attention, dedication, and time they invest in each case.’

‘High level of competence in every team member, detailed analysis and clear explanation of pro’s and con’s of each choice.’

‘Giulia Verusio possesses an exceptional depth of legal knowledge and expertise that is truly remarkable. What sets Giulia apart is her ability to translate legal concepts into clear, actionable advice.’

Key clients

Actavis Italy S.p.A.

Dentsply Sirona Italia S.r.l.

Euroapi Italy S.r.l

Grifols Italia S.p.A.

Havas PR Milan S.r.l.

Health Italia S.p.A.

Progenika Biopharma S.A.

Sciterion S.r.l.

SDM Società Dietetica Medica S.r.l.

Sic. Or. S.r.l.

TEVA Italia S.r.l.

Work highlights

  • Advising Grifols Italia on successfully appealing two “photographic tenders” before the Regional Administrative Court of Lazio, leading to annulment of restrictive rules.
  • Advising on the management of the requests for repayment of exceeding medical devices expenditure at national and regional levels for the years 2015 through 2018.
  • Advising Professional Case Management Clinical Trials, LLC and PCM Clinical Trials International, Ltd on the development of new models for decentralised clinical trials outside the United States.

Pavia e Ansaldo

Pavia e Ansaldo has longstanding experience in the healthcare and life sciences sector, and it maintains active communication with globally significant regulatory bodies including the European Medicines Agency and the US Food and Drug Administration. The firm is expert in advising major pharmaceutical and biotechnology clients on IP litigation, regulatory, M&A, competition and data protection matters with an international element. Gian Paolo Di Santo leads the firm’s life sciences practice alongside his IP litigation, corporate and regulatory work for leading multinationals in the life sciences industry.

Practice head(s):

Gian Paolo Di Santo

Work highlights

Trevisan & Cuonzo

Trevisan & Cuonzo is noted for its expertise in litigation assistance connected to the pharmaceutical, biotech and medical devices sectors - all areas in which managing partner Gabriel Cuonzo is highly experienced. Donatella Capelli is well-versed in patent litigation and regulation, while Daniela Ampollini assists foreign and domestic clients in IP matters with a focus on the pharmaceutical and medical devices sectors. Luca Pellicciari supports clients through the regulatory aspects concerning pharmaceutical production and Federica Bocedi is also of note.

Practice head(s):

Gabriel Cuonzo; Donatella Capelli; Daniela Ampollini; Luca Pellicciari

Other key lawyers:

Federica Bocedi

Work highlights

Franzosi Dal Negro Setti

Franzosi Dal Negro Setti provides assistance at every point of the pharmaceutical product chain and other life sciences matters. The firm’s clients include multinational companies as well as smaller domestic clients. Francesco Setti is known for his mastery of pharmaceutical and healthcare law and regulations, while Stefano Giberti is very experienced in advising on the pharmaceutical and medical devices sectors, including on payback and administrative disputes. In addition, Francesca Libanori complements the practice with her deep knowledge of pharmaceutical regulation. In December 2023, Vincenzo Jandoli left the practice for Lexsential.


Practice head(s):

Francesco Setti; Stefano Giberti; Francesca Libanori

Work highlights

Gianni & Origoni

Gianni & Origoni assists its healthcare clients in the broad range of matters that arise in the sector, including acquisitions, licences, IP disputes, antitrust issues and labour matters. Its clients include pharmaceutical and biotech and medical device companies and public healthcare companies. Rosario Zaccà, the lead of the healthcare and life sciences practice, is well-versed in corporate and M&A, commercial, private equity and joint venture matters with a multi-jurisdictional element. In March 2023, Andrea Gritti departed the firm for Portolano Cavallo.

Practice head(s):

Rosario Zaccà

Key clients

Alchimia Sgr

ArchiMed S.a.S


Biofarma Group

Fondazione Luigi Maria Monti, owner of Istituto Dermopatico dell’Immacolata (IDI – IRCCS)

GE Medical System Italia

Herbalife Italia

Hippocrates Holding


Leadiant Group


Medac GmbH


Novartis AG / Novartis Farma

Novo Nordisk




Sanofi Aventis

Takeda Italia

Sharon Laboratories

Zambon Group

Work highlights

  • Advised in the litigation before the TAR Lazio against the decree of 6 July 2022 by which the Minister of Health quantified the reimbursement following the breach of the expenditure ceiling for medical devices for the years 2015, 2016, 2017 and 2018 and the decisions by which the Regions quantified the amounts to be paid by individual companies.
  • Advised Keensight Capital, one of the leading private equity managers dedicated to pan-European Growth Buyout1 investments, in the acquisition of a majority stake in Axxam, a leading innovative Partner Research Organization in the life sciences industry.
  • Advised Panakès Partners sgr, Italy’s leading venture capital firm in the life sciences sector, in setting up and launching the ‘Purple’ alternative investment fund, which reached hard cap at final closing with a fundraising of EUR 175 million.

LCA Studio Legale

LCA Studio Legale maintains a wide focus of practice, with experience advising in pharmaceutical, biotech, medical devices, healthcare, clinical trials, regulatory, M&A and litigation matters. Agostino Migone de Amicis is one of the heads of the healthcare and life sciences practice at the firm and regularly advises on corporate and regulatory matters with a particular focus on clinical trials. Andrea Carreri, the other practice head, is also noted for his assistance in pharmaceutical matters.

Practice head(s):

Andrea Carreri; Agostino Migone de Amicis


‘LCA Studio Legale demonstrates an extremely high level of expertise in the field of healthcare practice.’

‘This practice is made unique by the team leader, Agostino Migone.’

‘Agostino Migone has incredible experience.’

Key clients

APT S.r.l.

Bausch & Lomb-IOM S.p.a.

Dealfa S.r.l.

Didofà S.r.l.

Extractum Pharma Zrt

Gargofalo Health Care S.p.A.

GSK Vaccines S.r.l.

Habilita S.p.A.

Incyte Biosciences Italy S.r.l.

Instrumentation Laboratory S.p.A.

Janssen-Cilag S.p.A.

Kaneka Corporation (Japan)

Med Consulting S.r.l.

Suanfarma S.A.

Zentiva Italia S.r.l.

Work highlights

  • Representing Dealfa S.r.l., a leader in the marketing of special bandages and wound plasters, before the Administrative Court of Rome with regard to an appeal against the Italian payback system applicable to medical devices.
  • Advising the joint venture on the 30-year project financing concession for the design, construction and management of the Cittadella Sanitaria of the Treviso Hospital, which includes the construction of the Ca’ Foncello Hospital in two phases, the first of which has been completed.
  • Advised Garofalo Health Care S.p.A. on the acquisition of a 90% stake in Sanatorio Triestino S.p.A., which operates the oldest hospital in Friuli Venezia Giulia Region (in Trieste).

Legance - Avvocati Associati

Legance - Avvocati Associati assists foreign and domestic clients from across the sector, including hospitals, pharmaceutical and biotech companies. The firm maintains a strong expertise in the industry’s regulatory framework as well as matters involving corporate, IP, compliance, administrative and competition law. Giovanni Nardulli  is the firm’s head of practice and focuses his work on M&A matters, especially involving cross-border transactions. Pietro Merlino joined the firm in November 2023 from Orrick, Herrington & Sutcliffe.

Practice head(s):

Giovanni Nardulli

Other key lawyers:

Pietro Merlino; Lorenzo Gentiloni Silveri


‘The team is outstanding and responds promptly and accurately to all requests.’

‘Quality of the work and availability.

Key clients

Agilent Technologies

Allergy Therapeutics


Castello SGR S.p.A.

C.O.T. Cure Ortopediche Traumatologiche S.p.A.

Diamante S.r.l.


Entangled Capital SGR


LIRH Foundation

GB Pharma

GKSD Parking S.r.l

Gruppo San Donato

Gruppo San Donato East Europe

Gruppo Villa Maria

GSD Healthcare


Hippocrates Holding

IRCCS Ospedale San Raffaele

IRCCS Policlinico San Donato

Kolinpharma S.p.A

KOS Group

Medipass S.p.A.

MSD Italia

Ospedale Galeazzi S.p.A.


RiverForce Partners

Teva Italia


U.G.A. Nutraceuticals

Università Vita-Salute San Raffaele

Work highlights

  • Assisted UnipolSai in the acquisition, from the L-GAM investment fund, of the entire share capital of Società e Salute, a company operating in the private healthcare sector under the brand name Centro Medico Santagostino.
  • Assisted Ospedale San Raffaele (Scientific Institutes of Hospitalisation and Care (IRCCS)) and Università Vita-Salute San Raffaele for a partnership for the implementation and development of a neurotechnology laboratory, the Europe’s largest of Walk Again Project.
  • Assisted PRP in entering into an investment agreement and a shareholders’ agreement with Speira Quattro (a company ultimately controlled by Hyle Capital Partners SGR), in order to promote a voluntary tender offer for the entirety of Kolinpharma’s shares – through a special purpose vehicle in which PRP will reinvest its majority shareholding following the completion of the offer – aimed at delisting the company.

LS CUBE Studio Legale

LS CUBE Studio Legale maintains a focused practice in commercial, corporate and regulatory matters in life sciences. Paola La Licata has a wealth of experience in regulatory, compliance and commercial matters connected to the life sciences sector. Rosanna Sovani is noted for her market access expertise in the industry. Paolo Ricci focuses his life sciences practice on commercial, corporate and M&A matters. Massimiliano Marinozzi is also noted for his work in mass litigation.

Practice head(s):

Paolo Ricci; Paola La Licata; Massimiliano Marinozzi; Rosanna Sovani


‘A boutique firm with committed partners and associates who accompany the clients through the collaboration. A solid government relations and public policy practice which adds up to the legal questions that are being addressed.’

‘Paolo Ricci has a strategic mindset that helps addressing legal issues with a business perspective.’

‘Paola La Licata has in-depth knowledge of regulatory framework for medical devices and pharmaceutical products that provides insights into policy and legislative changes.’

Key clients

Actial Farmaceutici






Bristol Myers Squibb

Covington & Burling LLP


Daiichi Sankyo


Exact Sciences


Grant Thorton



IBSA Farmaceutici

Kyowa Kirin

Manni Oil


Ospedale Bambin Gesù





San Raffaele IRCS





Urgo Laboratories


Vertex Pharmaceutical

Work highlights

  • Assisted in a judicial proceeding aimed at challenging the insertion in the transparency list managed by the Italian Agency of Pharmaceutical Products of one of the main products commercialized by the company, being a narcotic product for the treatment of the ache of terminally ill cancer patients.
  • Assisted in the funding of the National Oncologic Plan with a specific funding of the Cancer Regional Network (Reti Oncologiche Regionali) and the provision of an innovative regional resource allocation mechanism based on the upon the achievement of certain goals.

Masotti Cassella

Masotti Cassella is accustomed to advising clients in a range of sectors, including medical devices, biotech and pharmaceuticals. The firm also advises on research and development and clinical trial agreements. Luca Masotti co-heads the firm’s life sciences department where he utilises his experience on corporate and M&A matters, including those involving international transactions. Joint co-head Carlo Piatti, is advises on banking, commercial, corporate, public law and litigation matters.

Practice head(s):

Luca Masotti; Carlo Piatti

Key clients

Ab Medica S.p.A.

Pharmalex GmbH

Glenmark Pharmaceuticals

Ab Medica France

Work highlights

  • Advising Pharmalex on the Italian aspects of the 1.2 billion dollar sale of its shares to AmersourceBergen.
  • Advising Glenmark on the acquisition of 100% shares in Sintesy Pharma SRL (cross-border transaction – Italy, Switzerland, India).
  • Defending one of our most important clients in a complex series of procedures (value: over 18 million Euro) challenging a decision of the Italian Government which was based on an unprecedented and very controversial law recently issued in Italy, that has already raised a large number of litigations started by medical device companies, as well as several debates on a national level, with extensive media coverage.


PedersoliGattai maintains a dedicated specialist healthcare and life sciences group. It advises on corporate and regulatory matters that may be contentious or non-contentious. The firm serves clients from the pharmaceutical, biotechnology and medical devices sectors. Luca Saraceni, who is expert in advising a broad spectrum of clients on M&A transactions in the healthcare and life sciences industry, leads the practice alongside Sergio Fienga, who is experienced in administrative and regulatory matters.

Practice head(s):

Luca Saraceni; Sergio Fienga

Key clients

Vista Vision


Advanced Sterilization Products Italia

Astidental Bquadro


Hollycon Italy

NTP Nano Tech Projects

NMS Group

Fondazione EBRI (European Brain Research Institute)

Work highlights

  • Assisting the shareholders of Plurima in the agreement between Poste Italiane and Opus, owned by the Marconi family, and private equity firm Siparex for the acquisition of a majority stake in Plurima, a leading Italian logistics company for the medical sector.
  • Assisted EXOR in the acquisition of a co-controlling interest in Lifenet, a company active in the healthcare sector in the management of hospitals and outpatient clinics, through the purchase of a shareholding from the majority shareholder, Invin, and the subscription of a capital increase of Lifenet, reserved for subscription to EXOR.
  • Assisted Astidental Bquadro, an Italian company specialising in the distribution of equipment and items for dentists, dental laboratories and dental clinics, in the sale of the majority stake in the company to Gioconda, the Italian branch of LBO France, through Small Caps Opportunities II fund.

Simmons & Simmons

Simmons & Simmons leverages its strength in IP matters on a domestic and international level in the healthcare and life sciences industry. The healthcare and life sciences practice is led by Stefania Bergia, who assists clients on domestic and international IP matters as well as competition and arbitration cases, and Giulio Enrico Sironi, who is experienced in contentious and non-contentious IP matters with an international element. The team has recently seen the arrival of European health and life sciences regulatory specialist Vincenzo Salvatore, who brings valuable expertise in EU life sciences regulation and compliance, advising clients on intricate matters related to pharmaceutical and medical products. Augusto Santoro left the firm in February 2023 for Herbert Smith Freehills.

Practice head(s):

Stefania Bergia; Giulio Enrico Sironi

Other key lawyers:

Vincenzo Salvatore


Very proactive collaboration, well organized team, timely and detailed exchanges.’

‘Really strong team in Italy, particularly Stefania.


Work highlights